This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lopez-Ribot, J. L.
Right arrow Articles by Patterson, T. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lopez-Ribot, J. L.
Right arrow Articles by Patterson, T. F.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, July 1999, p. 1621-1630, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Multiple Resistant Phenotypes of Candida albicans Coexist during Episodes of Oropharyngeal Candidiasis in Human Immunodeficiency Virus-Infected Patients

Jose L. Lopez-Ribot,1,* Robert K. McAtee,1 Sofia Perea,1 William R. Kirkpatrick,1 Michael G. Rinaldi,2,3 and Thomas F. Patterson1

Departments of Medicine1 and Pathology,2 The University of Texas Health Science Center at San Antonio, and South Texas Veterans Health Care System, Audie L. Murphy Division,3 San Antonio, Texas 78284

Received 8 February 1999/Returned for modification 29 March 1999/Accepted 7 May 1999

Mechanisms of resistance to azoles in Candida albicans, the main etiologic agent of oropharyngeal candidiasis (OPC), include alterations in the target enzyme (lanosterol demethylase) and increased efflux of drug. Previous studies on mechanisms of resistance have been limited by the fact that only a single isolate from each OPC episode was available for study. Multiple isolates from each OPC episode were evaluated with oral samples plated in CHROMagar Candida with and without fluconazole to maximize detection of resistant yeasts. A total of 101 isolates from each of three serial episodes of OPC from four different patients were evaluated. Decreasing geometric means of fluconazole MICs with serial episodes of infection were detected in the four patients. However, 8-fold or larger (up to 32-fold) differences in fluconazole MICs were detected within isolates recovered at the same time point in 7 of 12 episodes. Strain identity was analyzed by DNA typing techniques and indicated that isolates from each patient represented mainly isogenic strains, but differed among patients. A Northern blot technique was used to monitor expression of ERG11 (encoding lanosterol demethylase) and genes coding for efflux pumps. This analysis revealed that clinical isolates obtained from the same patient and episode were phenotypically heterogeneous in their patterns of expression of these genes involved in fluconazole resistance. These results demonstrate the complexity of the distribution of the molecular mechanisms of antifungal drug resistance and indicate that different subpopulations of yeasts may coexist at a given time in the same patient and may develop resistance through different mechanisms.

* Corresponding author. Mailing address: Department of Medicine, Division of Infectious Diseases, The University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Dr., San Antonio, TX 78284-7881. Phone: (210) 567-1981. Fax: (210) 567-3303. E-mail: ribot{at}uthscsa.edu.

Antimicrobial Agents and Chemotherapy, July 1999, p. 1621-1630, Vol. 43, No. 7
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Dalle, F., Lafon, I., L'Ollivier, C., Ferrant, E., Sicard, P., Labruere, C., Jebrane, A., Laubriet, A., Vagner, O., Caillot, D., Bonnin, A. (2008). A prospective analysis of the genotypic diversity and dynamics of the Candida albicans colonizing flora in neutropenic patients with de novo acute leukemia. haematol 93: 581-587 [Abstract] [Full Text]  
  • Alexander, B. D., Byrne, T. C., Smith, K. L., Hanson, K. E., Anstrom, K. J., Perfect, J. R., Reller, L. B. (2007). Comparative Evaluation of Etest and Sensititre YeastOne Panels against the Clinical and Laboratory Standards Institute M27-A2 Reference Broth Microdilution Method for Testing Candida Susceptibility to Seven Antifungal Agents. J. Clin. Microbiol. 45: 698-706 [Abstract] [Full Text]  
  • Andes, D., Forrest, A., Lepak, A., Nett, J., Marchillo, K., Lincoln, L. (2006). Impact of Antimicrobial Dosing Regimen on Evolution of Drug Resistance In Vivo: Fluconazole and Candida albicans.. Antimicrob. Agents Chemother. 50: 2374-2383 [Abstract] [Full Text]  
  • Pfaller, M. A., Diekema, D. J., Sheehan, D. J. (2006). Interpretive Breakpoints for Fluconazole and Candida Revisited: a Blueprint for the Future of Antifungal Susceptibility Testing. Clin. Microbiol. Rev. 19: 435-447 [Abstract] [Full Text]  
  • Murray, C K, Beckius, M L, Green, J A, Hospenthal, D R (2005). Use of chromogenic medium in the isolation of yeasts from clinical specimens. J Med Microbiol 54: 981-985 [Abstract] [Full Text]  
  • Pasrija, R., Krishnamurthy, S., Prasad, T., Ernst, J. F., Prasad, R. (2005). Squalene epoxidase encoded by ERG1 affects morphogenesis and drug susceptibilities of Candida albicans. J Antimicrob Chemother 55: 905-913 [Abstract] [Full Text]  
  • Takakura, N., Wakabayashi, H., Ishibashi, H., Yamauchi, K., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S. (2004). Effect of orally administered bovine lactoferrin on the immune response in the oral candidiasis murine model. J Med Microbiol 53: 495-500 [Abstract] [Full Text]  
  • Rodero, L., Mellado, E., Rodriguez, A. C., Salve, A., Guelfand, L., Cahn, P., Cuenca-Estrella, M., Davel, G., Rodriguez-Tudela, J. L. (2003). G484S Amino Acid Substitution in Lanosterol 14-{alpha} Demethylase (ERG11) Is Related to Fluconazole Resistance in a Recurrent Cryptococcus neoformans Clinical Isolate. Antimicrob. Agents Chemother. 47: 3653-3656 [Abstract] [Full Text]  
  • Takakura, N., Wakabayashi, H., Ishibashi, H., Teraguchi, S., Tamura, Y., Yamaguchi, H., Abe, S. (2003). Oral Lactoferrin Treatment of Experimental Oral Candidiasis in Mice. Antimicrob. Agents Chemother. 47: 2619-2623 [Abstract] [Full Text]  
  • Horvath, L. L., Hospenthal, D. R., Murray, C. K., Dooley, D. P. (2003). Direct Isolation of Candida spp. from Blood Cultures on the Chromogenic Medium CHROMagar Candida. J. Clin. Microbiol. 41: 2629-2632 [Abstract] [Full Text]  
  • Gauthier, C., Weber, S., Alarco, A.-M., Alqawi, O., Daoud, R., Georges, E., Raymond, M. (2003). Functional Similarities and Differences between Candida albicans Cdr1p and Cdr2p Transporters. Antimicrob. Agents Chemother. 47: 1543-1554 [Abstract] [Full Text]  
  • Mukhopadhyay, K., Kohli, A., Prasad, R. (2002). Drug Susceptibilities of Yeast Cells Are Affected by Membrane Lipid Composition. Antimicrob. Agents Chemother. 46: 3695-3705 [Abstract] [Full Text]  
  • Ramage, G., Bachmann, S., Patterson, T. F., Wickes, B. L., Lopez-Ribot, J. L. (2002). Investigation of multidrug efflux pumps in relation to fluconazole resistance in Candida albicans biofilms. J Antimicrob Chemother 49: 973-980 [Abstract] [Full Text]  
  • Kohli, A., Smriti, N., Mukhopadhyay, K., Rattan, A., Prasad, R. (2002). In Vitro Low-Level Resistance to Azoles in Candida albicans Is Associated with Changes in Membrane Lipid Fluidity and Asymmetry. Antimicrob. Agents Chemother. 46: 1046-1052 [Abstract] [Full Text]  
  • Martinez, M., Lopez-Ribot, J. L., Kirkpatrick, W. R., Bachmann, S. P., Perea, S., Ruesga, M. T., Patterson, T. F. (2002). Heterogeneous mechanisms of azole resistance in Candida albicans clinical isolates from an HIV-infected patient on continuous fluconazole therapy for oropharyngeal candidosis. J Antimicrob Chemother 49: 515-524 [Abstract] [Full Text]  
  • Martinez, A., Ferrer, S., Santos, I., Jimenez, E., Sparrowe, J., Regadera, J., De Las Heras, F. G., Gargallo-Viola, D. (2001). Antifungal Activities of Two New Azasordarins, GW471552 and GW471558, in Experimental Models of Oral and Vulvovaginal Candidiasis in Immunosuppressed Rats. Antimicrob. Agents Chemother. 45: 3304-3309 [Abstract] [Full Text]  
  • Perea, S., Lopez-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillan, R. A., Martinez, M., Calabrese, D., Sanglard, D., Patterson, T. F. (2001). Prevalence of Molecular Mechanisms of Resistance to Azole Antifungal Agents in Candida albicans Strains Displaying High-Level Fluconazole Resistance Isolated from Human Immunodeficiency Virus-Infected Patients. Antimicrob. Agents Chemother. 45: 2676-2684 [Abstract] [Full Text]  
  • Tanida, T., Rao, F., Hamada, T., Ueta, E., Osaki, T. (2001). Lactoferrin Peptide Increases the Survival of Candida albicans- Inoculated Mice by Upregulating Neutrophil and Macrophage Functions, Especially in Combination with Amphotericin B and Granulocyte-Macrophage Colony-Stimulating Factor. Infect. Immun. 69: 3883-3890 [Abstract] [Full Text]  
  • Martinez, A., Regadera, J., Jimenez, E., Santos, I., Gargallo-Viola, D. (2001). Antifungal Efficacy of GM237354, a Sordarin Derivative, in Experimental Oral Candidiasis in Immunosuppressed Rats. Antimicrob. Agents Chemother. 45: 1008-1013 [Abstract] [Full Text]  
  • Dalle, F., Franco, N., Lopez, J., Vagner, O., Caillot, D., Chavanet, P., Cuisenier, B., Aho, S., Lizard, S., Bonnin, A. (2000). Comparative Genotyping of Candida albicans Bloodstream and Nonbloodstream Isolates at a Polymorphic Microsatellite Locus. J. Clin. Microbiol. 38: 4554-4559 [Abstract] [Full Text]  
  • Barchiesi, F., Calabrese, D., Sanglard, D., Falconi Di Francesco, L., Caselli, F., Giannini, D., Giacometti, A., Gavaudan, S., Scalise, G. (2000). Experimental Induction of Fluconazole Resistance in Candida tropicalis ATCC 750. Antimicrob. Agents Chemother. 44: 1578-1584 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»